Zynerba Pharmaceuticals Inc. (ZYNE)

6.79 -0.5 (-6.859%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 7.29

Price Open 7.29

Volume: 597,642

Avg Volume: 491,583

Market Cap: 119.67M

P/E Ratio -2.24

52 Wk Range 5.59-15.1349



ZYNE Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
15.5M
2.57M
3.17
16.61%

2018-09-14
15.5M
2M
3.41
12.91%

2018-08-31
15.5M
1.78M
2.59
11.50%

2018-08-15
15.53M
1.7M
2.43
10.94%




ZYNE Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-02
Q2 2018
BTO
-0.77 (3)
-0.89
-0.12

2018-05-08
Q1 2018
N/A
-0.64 (5)
-0.91
-0.27

2018-03-26
Q4 2017
N/A
-0.61 (5)
-0.91
-0.27

2018-03-12
Q4 2017
N/A
-0.61 (5)
-0.91
-0.27

News

Premarket Gainers as of 9:05 am (2018-09-21 09:22 SeekingAlpha)

GLT +49% . More news on: Glatfelter, DAVIDs TEA, Oasmia Pharmaceutical, Stocks on the move, , Top stock market news, Read more …

 


Statistics

Shares Outstanding: 17.62M

Top 15 Institution Percent: 18.00

Price To Sales: N/A

Price To Book: 3.21

Revenue: N/A

Gross Profit: N/A

Cash: 66.25M

Debt: N/A

Return On Assets: -62.06

Return On Equity: -73.21

Profit Margin: N/A

Price History

Beta: 4.30

50-day Moving Avg: 7.26

200-day Moving Avg: 9.36

YTD Change: -47.75

5-day Change: -5.56

1-month Change: -6.86

3-month Change: -33.30

6-month Change: -31.83

1-year Change: -27.69

Revenue Per Share: 0.00

Revenue Per Employee: 0.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Zynerba Pharmaceuticals Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.zynerba.com

Zynerba Pharmaceuticals Inc together with its subsidiary is a pharmaceutical company which is focused on developing and commercializing proprietary next generation synthetic cannabinoid therapeutics formulated for transdermal delivery.